Title: Alexander LT, et al. Type II Inhibitors Targeting CDK2. ACS Chem Biol. 2015 Sep 18;10(9):2116-25.
Title: Jones K, et al. Cancer Drug Discovery 2010: from molecules to medicine. Expert Rev Clin Pharmacol. 2010 Sep;3(5):613-5.
1421227-53-3
1421227-52-2
630124-46-8
1547339-60-5 | (3-ethyl-1-naphthalenyl)(1-pentyl-1H-indol-3-yl)-methanone | AA01EOV2 | MFCD23135871
1971007-87-0 | N-[[1-(5-fluoropentyl)-1H-indol-3-yl]carbonyl]-L-valine,methylester | AA01EP4Q
1539266-51-7 | 4-(ethylthio)-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine,monohydrochloride | AA01EPD8
1062169-46-3 | 4-[6-[4-[[(cyclopropylamino)carbonyl]amino]phenyl]-4-(4-morpholinyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinecarboxylicacid,methylester | AA01EPJT
1438278-55-7 | 1-(1-butyl-7-methoxy-1H-indol-3-yl)-2-(1-naphthalenyl)-ethanone | AA01EPPK
105878-43-1 | 1-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanol,(2E)-2-monobutenedioate | AA01EPWO | MFCD00792743
1318025-75-0 | (2S,4aR,4bR,6aS,12aS,12bR,14aR)-2-(acetyloxy)-2,3,4,4a,4b,5,6,6a,12,12a,12b,13,14,14a-tetradecahydro-1,1,4a,6a,9,12b-hexamethyl-1H,11H-phenanthro[2,1-b]pyrano[3,4-e]pyran-11-one | AA01EQ60
936449-28-4 | PDE5inhibitor42 | AA01EQC7 | MFCD22123238
1141893-10-8 | (S)-tert-Butyl 3-(ethylamino)piperidine-1-carboxylate | AA01EQP0 | MFCD21097962
1286208-96-5 | (R)-(3-Aminopyrrolidin-1-yl)(tetrahydro-2H-pyran-4-yl)methanone hydrochloride | AA01ERPG | MFCD18378101
